QCG
MDT icon

Quadrant Capital Group’s Medtronic MDT Stock Holding History

Quadrant Capital Group’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.63M Sell
18,788
-13,689
-42% -$1.31M 0.05% 353
2025
Q4 		$3.12M Buy
32,477
+101
+0.3% +$9.81K 0.09% 160
2025
Q3 		$3.08M Buy
32,376
+17,191
+113% +$1.58M 0.1% 155
2025
Q2 		$1.32M Buy
15,185
+3,267
+27% +$277K 0.05% 353
2025
Q1 		$1.07M Buy
11,918
+8,241
+224% +$737K 0.04% 362
2024
Q4 		$294K Sell
3,677
-97
-3% -$8.4K 0.02% 487
2024
Q3 		$340K Buy
3,774
+183
+5% +$15.4K 0.02% 462
2024
Q2 		$283K Buy
3,591
+99
+3% +$8.12K 0.02% 503
2024
Q1 		$305K Sell
3,492
-851
-20% -$72.6K 0.02% 465
2023
Q4 		$358K Sell
4,343
-1,330
-23% -$101K 0.03% 388
2023
Q3 		$445K Sell
5,673
-1,141
-17% -$95.5K 0.04% 291
2023
Q2 		$600K Sell
6,814
-157
-2% -$13.5K 0.06% 223
2023
Q1 		$562K Buy
6,971
+2,328
+50% +$190K 0.06% 236
2022
Q4 		$361K Sell
4,643
-466
-9% -$37.8K 0.04% 322
2022
Q3 		$413K Buy
5,109
+318
+7% +$28.6K 0.05% 243
2022
Q2 		$430K Sell
4,791
-1,865
-28% -$189K 0.06% 247
2022
Q1 		$739K Buy
6,656
+2,111
+46% +$223K 0.09% 163
2021
Q4 		$470K Sell
4,545
-2,352
-34% -$272K 0.06% 225
2021
Q3 		$865K Buy
6,897
+511
+8% +$66.1K 0.12% 126
2021
Q2 		$793K Buy
6,386
+629
+11% +$79K 0.12% 131
2021
Q1 		$680K Buy
5,757
+1,000
+21% +$117K 0.11% 134
2020
Q4 		$557K Buy
4,757
+414
+10% +$45.6K 0.1% 137
2020
Q3 		$451K Sell
4,343
-554
-11% -$55.6K 0.1% 139
2020
Q2 		$449K Buy
4,897
+1,473
+43% +$141K 0.1% 147
2020
Q1 		$312K Sell
3,424
-3,312
-49% -$352K 0.05% 284
2019
Q4 		$740K Buy
6,736
+1,722
+34% +$189K 0.09% 186
2019
Q3 		$528K Buy
5,014
+2,400
+92% +$250K 0.08% 226
2019
Q2 		$240K Sell
2,614
-1,347
-34% -$123K 0.04% 480
2019
Q1 		$344K Buy
3,961
+1,384
+54% +$124K 0.06% 311
2018
Q4 		$221K Buy
2,577
+265
+11% +$24.8K 0.06% 313
2018
Q3 		$212K Buy
2,312
+111
+5% +$10.3K 0.06% 231
2018
Q2 		$174K Buy
2,201
+188
+9% +$15.7K 0.06% 273
2018
Q1 		$150K Buy
2,013
+298
+17% +$24.6K 0.05% 304
2017
Q4 		$128K Buy
1,715
+199
+13% +$15.9K 0.05% 324
2017
Q3 		$108K Sell
1,516
-123
-8% -$10.2K 0.04% 367
2017
Q2 		$114K Buy
1,639
+290
+21% +$24.5K 0.05% 309
2017
Q1 		$99K Sell
1,349
-880
-39% -$68.7K 0.04% 358
2016
Q4 		$148K Sell
2,229
-409
-16% -$32.1K 0.07% 195
2016
Q3 		$216K Buy
2,638
+265
+11% +$23.1K 0.14% 125
2016
Q2 		$194K Sell
2,373
-931
-28% -$75.3K 0.13% 129
2016
Q1 		$238K Buy
3,304
+360
+12% +$27.1K 0.15% 104
2015
Q4 		$218K Sell
2,944
-911
-24% -$68.6K 0.15% 129
2015
Q3 		$253K Sell
3,855
-1,368
-26% -$101K 0.17% 101
2015
Q2 		$379K Buy
+5,223
New +$399K 0.24% 82

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Quadrant Capital Group's MDT Position: Q1 2026 in Review

Quadrant Capital Group reduced its Medtronic (MDT) stake by 42% in Q1 2026, selling an estimated $1.31M and leaving 18,788 shares worth $1.63M. The position accounts for 0.05% of the portfolio, ranked #353.

Quadrant Capital Group first reported a position in MDT in Q2 2015 and has held it in 44 quarters since. The position peaked at $3.12M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Quadrant Capital Group held 18,788 shares of Medtronic worth $1.63M as of Q1 2026.
  • Quadrant Capital Group sold 13,689 Medtronic shares in Q1 2026, an estimated $1.31M.
  • Medtronic made up 0.05% of Quadrant Capital Group's portfolio in Q1 2026, its #353 holding.
  • Quadrant Capital Group first reported a position in Medtronic in Q2 2015 and has held it in 44 quarters since.
  • Quadrant Capital Group's Medtronic position peaked at $3.12M in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.